封面
市場調查報告書
商品編碼
1329147

全球生物晶片市場

Biochips

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 369 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年全球生物晶片市場規模將達408億美元

在Covid-19後商業環境發生變化的情況下,全球生物晶片市場預計2022年為159億美元,預計到2030年將達到408億美元,複合年複合成長率預計將成長12.5%。 DNA 晶片是本報告分析的細分市場之一,預計複合年成長率為 11.4%,到分析期結束時將達到 135 億美元。鑑於大流行後的持續復甦,晶片實驗室領域的成長已將未來八年的年複合成長率修正為 13.1%。

美國市場預計將成長63億美元,中國年複合成長率為14.8%

到2022年,美國生物晶片市場預計將達到63億美元。中國作為世界第二大經濟體,預計到2030年市場規模將達到42億美元,2022年至2030年復合年成長率為14.8%。其他值得注意的地域市場包括日本和加拿大,預計 2022 年至 2030 年將分別成長 10.7% 和 11.2%。在歐洲,德國的年複合成長率預計約為 12.5%。

受訪企業示例

  • Eppendorf AG
  • Fluidigm Corporation
  • F. Hoffmann-La Roche AG
  • IntegraGen SA
  • Agendia NV
  • Ocimum Biosolutions Ltd.
  • Analis SA/NV
  • Empire Genomics LLC
  • Mobidiag
  • AVIVA BioSciences Corporation
  • Little Things Factory GmbH
  • IDEX Health & Science LLC
  • Arround Inc.
  • As One Corporation
  • Cala Del Forte

目錄

第1章 調查方法

第2章 執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 拉丁美洲
  • 世界其他地區

第4章 競爭

簡介目錄
Product Code: MCP-1026

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Biochips Market to Reach $40.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Biochips estimated at US$15.9 Billion in the year 2022, is projected to reach a revised size of US$40.8 Billion by 2030, growing at a CAGR of 12.5% over the analysis period 2022-2030. DNA Chip, one of the segments analyzed in the report, is projected to record a 11.4% CAGR and reach US$13.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Lab-On-a-chip segment is readjusted to a revised 13.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $6.3 Billion, While China is Forecast to Grow at 14.8% CAGR

The Biochips market in the U.S. is estimated at US$6.3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2030 trailing a CAGR of 14.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.7% and 11.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 12.5% CAGR.

Select Competitors (Total 69 Featured) -

  • Eppendorf AG
  • Fluidigm Corporation
  • F. Hoffmann-La Roche AG
  • IntegraGen SA
  • Agendia NV
  • Ocimum Biosolutions Ltd.
  • Analis SA/NV
  • Empire Genomics LLC
  • Mobidiag
  • AVIVA BioSciences Corporation
  • Little Things Factory GmbH
  • IDEX Health & Science LLC
  • Arround Inc.
  • As One Corporation
  • Cala Del Forte

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • 2020 Marked as a Year of Disruption & Transformation
    • World Economic Growth Projections (Real GDP, Annual % Change) for 2019 to 2022
    • Biotechnology Sector Performance amid the Pandemic
    • Global Biotechnology Market Reset & Trajectory - Growth Outlook (In %) For Years 2019 Through 2025
    • Biochip Firms Get Ready to Address COVID-19 Challenge
    • Biochips - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Biochips: A Primer
    • Manufacturing Systems Used in Biochip Manufacture
    • Historical Perspective
    • Classification of Biochips
    • Application Markets
    • Market Outlook
    • Protein Biochips Set for Expansion
    • Recent Technological Advancements Drive Wider Adoption of Biochips
    • Competition
    • Biotech Startups Pose Competition
    • Recent Market Activity
    • World Brands
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Biochips Seek Increasing Role in POC Testing
    • Biochips to Help Next-Generation Sequencing Scale New Heights & Unravel Intimidating Biological Problems
    • Research Forays into Organ-On-A-Chip (OOC)
    • OCC Start-Ups Enter the Fray
    • Select Organ-On-A-Chip Start-Ups & Their Specialties
    • Biochip Implants Set to Make Big Gains
    • Biochips Aid in Alleviating Issues Associated with Immunological Studies
    • Challenges for Widespread Adoption
    • Drug Discovery Applications to Drive Market
    • Growing Preference for DNA/Protein Biochips in Personalized Medicine
    • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
    • Microphysiological Systems to Take Personalized Medicine Much Farther
    • Biochip Array Technology Enables Reliable and Accurate Investigation of Metabolic Syndrome
    • Proteomics and Genomics Drive Opportunities for Biochips
    • Increasing Application of Genomics and Proteomics in Cancer Diagnostics and Treatment to Drive Growth
    • Breakdown of Total Number of Cancer Cases by Region: 2020
    • Breakdown of Total Number of Cancer Cases by Type: 2020
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Potential Application of Biochips in Diabetes Diagnosis and Management Unfurl New Growth Opportunities
    • World Diabetes and Population Statistics (2019, 2030 & 2045)
    • World Diabetes Prevalence (2000-2019)
    • Rise in Infectious Diseases and Need for High-Troughput Diagnosis Drive Interest in Biochips
    • Infection Rates of Viruses ((per infected person)) Involved in Outbreaks Worldwide: 2020
    • Infectious Diseases Related Mortality High Among Children Below 5 Years: Breakdown of Leading Causes of Death in Children Below 5 Years (in %)
    • Global Number of Deaths Caused Due to Communicable Diseases (In 000s)
    • Agriculture Sector: Niche Vertical
    • Development of Protein Microarrays for the Field of Diagnostics: Key Challenges
    • Biochip Industry Thrives on Innovation
    • Researchers at UCI Develop Machine Learning-Assisted Biochip
    • New Biochip Combines Nanoparticle Printing and AI for Tumor Analysis
    • Axbio Introduces Smartbiochip
    • Multi-Dimensional Printing Technology Enables Development of New Biochip Printing Technique
    • MIT Develops Neuromorphic Chip Capable of Mimicking Human Brain
    • Biochips from AYOXXA: A Giant Leap in Protein Multiplexing
    • Biochip Innovations in Drug Discovery Applications
    • Industry Challenges
    • Standardization: A Key Challenge
    • High Costs Restrain Growth
    • Precise Protein Detection: A Challenge
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for DNA Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for DNA Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for DNA Chip by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Lab-on-a-Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Lab-on-a-Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Lab-on-a-Chip by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Protein Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Protein Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Protein Chip by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Genomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Agriculture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 27: World 16-Year Perspective for Agriculture by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 30: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 31: World Biochips Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: World 16-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2023 & 2030
  • JAPAN
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2023 & 2030
  • CHINA
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: China 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: China 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2023 & 2030
  • EUROPE
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Biochips by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Biochips by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
  • FRANCE
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: France 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: France 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2023 & 2030
  • GERMANY
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: Germany 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: Italy 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: UK 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: UK 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: Spain 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 95: Spain Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Spain Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: Spain 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: Russia 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 101: Russia Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Russia Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: Russia 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Rest of Europe 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 107: Rest of Europe Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Rest of Europe Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: Rest of Europe 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: Asia-Pacific 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • Biochips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 116: Latin America Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Latin America Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: Latin America 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 119: Latin America Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Latin America Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: Latin America 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Rest of World Historic Review for Biochips by Product Type - DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: Rest of World 16-Year Perspective for Biochips by Product Type - Percentage Breakdown of Value Revenues for DNA Chip, Lab-on-a-Chip, Protein Chip and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 125: Rest of World Recent Past, Current & Future Analysis for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications - Independent Analysis of Annual Revenues in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Rest of World Historic Review for Biochips by Application - Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: Rest of World 16-Year Perspective for Biochips by Application - Percentage Breakdown of Value Revenues for Drug Discovery & Development, Disease Diagnostics, Genomics, Proteomics, Agriculture and Other Applications for the Years 2014, 2023 & 2030

IV. COMPETITION